Haemonetics HAE Proceeds from employee stock purchase plan
Proceeds from employee stock purchase plan at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's proceeds from employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's proceeds from employee stock purchase plan?
- Haemonetics (HAE) reported proceeds from employee stock purchase plan of $1.79M in Q1 2026.
- How has Haemonetics's proceeds from employee stock purchase plan changed year-over-year?
- Haemonetics's proceeds from employee stock purchase plan decreased by 3.4% year-over-year, from $1.86M to $1.79M.
- What is the long-term trend for Haemonetics's proceeds from employee stock purchase plan?
- Over 3 years (2023 to 2026), Haemonetics's proceeds from employee stock purchase plan has grown at a 4.0% compound annual growth rate (CAGR), from $7.02M to $7.89M.
- What does proceeds from employee stock purchase plan mean?
- This metric represents the cash proceeds received by the company from employees participating in stock purchase plans. It reflects the capital inflow generated when employees exercise their right to purchase company shares, typically at a discounted rate. This serves as an indicator of employee engagement and provides a non-dilutive source of financing for corporate operations.